Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. Top News .

The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...

MONDAY, Sept. 16, 2024 (HealthDay News) -- Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic ...

They also lost weight and had better liver function. THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A study reveals significan ...

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. Researchers administered weekly injections — either a placebo or ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

Researchers have drawn a connection between Ozempic and the prevention of liver diseases in specific patients. Getty Images/iStockphoto That sample was then divided into those who had taken GLP-1 ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition affecting millions of Americans.

They also lost weight and had better liver function. THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new ...

Obesity and diabetes can trigger a dangerous buildup of fat in the liver known as MASLD New data shows that use of a GLP-1 diabetes drug like Ozempic can stop MASLD from progressing to even more ...

THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many ...